DK196088A - Rekombinant htlv-iii protein og anvendelse deraf - Google Patents

Rekombinant htlv-iii protein og anvendelse deraf

Info

Publication number
DK196088A
DK196088A DK196088A DK196088A DK196088A DK 196088 A DK196088 A DK 196088A DK 196088 A DK196088 A DK 196088A DK 196088 A DK196088 A DK 196088A DK 196088 A DK196088 A DK 196088A
Authority
DK
Denmark
Prior art keywords
iii protein
recombinant htlv
htlv
recombinant
protein
Prior art date
Application number
DK196088A
Other languages
Danish (da)
English (en)
Other versions
DK196088D0 (da
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of DK196088D0 publication Critical patent/DK196088D0/da
Publication of DK196088A publication Critical patent/DK196088A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/22Viral peptide or viral protein
    • Y10S930/221Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK196088A 1987-10-09 1988-04-11 Rekombinant htlv-iii protein og anvendelse deraf DK196088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10770387A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
DK196088D0 DK196088D0 (da) 1988-04-11
DK196088A true DK196088A (da) 1989-04-10

Family

ID=22318013

Family Applications (1)

Application Number Title Priority Date Filing Date
DK196088A DK196088A (da) 1987-10-09 1988-04-11 Rekombinant htlv-iii protein og anvendelse deraf

Country Status (10)

Country Link
EP (1) EP0311228A3 (no)
JP (1) JPH01193299A (no)
KR (1) KR890006672A (no)
AU (1) AU614535B2 (no)
DK (1) DK196088A (no)
FI (1) FI882741A (no)
IL (1) IL86153A0 (no)
NO (1) NO881502L (no)
NZ (1) NZ224393A (no)
PT (1) PT87207A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
NZ251582A (en) * 1992-04-01 1997-07-27 Merck & Co Inc Recombinant human anti-hiv antibodies, methods for their cloning and expression and pharmaceutical compositions thereof
WO1994000151A1 (en) 1992-06-18 1994-01-06 Creagen, Inc. Combinatorial polypeptide antigens
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD147855A5 (de) * 1978-12-22 1981-04-22 Biogen Nv Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
JPS5761110A (en) * 1980-09-30 1982-04-13 Kitagawa Tekkosho:Kk Formation of columnar solidified portion in soft ground
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus

Also Published As

Publication number Publication date
NZ224393A (en) 1990-08-28
NO881502L (no) 1989-04-10
FI882741A (fi) 1989-04-10
KR890006672A (ko) 1989-06-15
EP0311228A2 (en) 1989-04-12
NO881502D0 (no) 1988-04-07
PT87207A (pt) 1989-07-31
FI882741A0 (fi) 1988-06-09
EP0311228A3 (en) 1990-05-02
AU614535B2 (en) 1991-09-05
DK196088D0 (da) 1988-04-11
JPH01193299A (ja) 1989-08-03
IL86153A0 (en) 1988-11-15
AU2117388A (en) 1989-04-27

Similar Documents

Publication Publication Date Title
DK299087D0 (da) Proteins and derivatives thereof
DK47285D0 (da) Renininhiberende peptider og anvendelsen deraf
DK285388D0 (da) Peptid og dets anvendelse
DK275788D0 (da) Protein
DK183488D0 (da) Furanderivater og anvendelse deraf
DK353788D0 (da) Polypeptidderivater
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DK413187D0 (da) Semicarbazoner og thiosemicarbazoner
DK196088D0 (da) Rekombinant htlv-iii protein og anvendelse deraf
DK698188A (da) Peptider, deres fremstilling og anvendelse
DK467087A (da) Lymphocytaktiverende polypeptider og deres anvendelse
DK354989A (da) Modificerede proteiner
DK285288D0 (da) Peptid og dets anvendelse
DK627389D0 (da) Proteiner og derivater deraf
IS3269A7 (is) Ný peptíð og notkun þeirra
DK596888A (da) Rekombinant lymfotoksin
DK90087D0 (da) Stillads og stilladsbuk dertil
ZA883261B (en) Recombinant htlv-iii proteins and uses thereof
IT8767012A0 (it) Peptidi anoressizzanti e ipotensivi
DK624089D0 (da) Polypeptidforbindelser
DK108389D0 (da) Mopstativ og mop
DK238585D0 (da) Peptider og fremstilling deraf
IS3300A7 (is) Ný fjölpeptíð og notkun þeirra.
DK125786D0 (da) Peptider og fremstilling deraf
SE8702724D0 (sv) Proteins and protein compositions and their use

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment